Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922

Chunyan Wang(Beijing Institute of Technology), Chen Chen Jiang(Hunter Medical Research Institute)
Oncotarget
July 6, 2016
Cited by 15


Related Papers